DK2207790T3 - Biologisk aktive C-terminalt argininholdige peptider - Google Patents
Biologisk aktive C-terminalt argininholdige peptiderInfo
- Publication number
- DK2207790T3 DK2207790T3 DK08829747.8T DK08829747T DK2207790T3 DK 2207790 T3 DK2207790 T3 DK 2207790T3 DK 08829747 T DK08829747 T DK 08829747T DK 2207790 T3 DK2207790 T3 DK 2207790T3
- Authority
- DK
- Denmark
- Prior art keywords
- biologically active
- containing peptides
- terminal arginine
- arginine
- terminal
- Prior art date
Links
- 239000004475 Arginine Substances 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 title 1
- 210000004899 c-terminal region Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96764407P | 2007-09-05 | 2007-09-05 | |
| PCT/US2008/075403 WO2009033024A1 (en) | 2007-09-05 | 2008-09-05 | Biologically active c-terminal arginine-containing peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2207790T3 true DK2207790T3 (da) | 2013-10-28 |
Family
ID=40084302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08829747.8T DK2207790T3 (da) | 2007-09-05 | 2008-09-05 | Biologisk aktive C-terminalt argininholdige peptider |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US20090143248A1 (enExample) |
| EP (1) | EP2207790B1 (enExample) |
| JP (1) | JP5734653B2 (enExample) |
| CN (2) | CN101848925A (enExample) |
| CA (1) | CA2697519C (enExample) |
| CY (1) | CY1114618T1 (enExample) |
| DK (1) | DK2207790T3 (enExample) |
| ES (1) | ES2434829T3 (enExample) |
| HR (1) | HRP20131108T1 (enExample) |
| PL (1) | PL2207790T3 (enExample) |
| PT (1) | PT2207790E (enExample) |
| SG (2) | SG10201803541TA (enExample) |
| SI (1) | SI2207790T1 (enExample) |
| WO (1) | WO2009033024A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20131108T1 (hr) * | 2007-09-05 | 2014-01-31 | Genentech, Inc. | Biološki aktivan arginin koji na c-završetku sadrži peptide |
| DE102010001983A1 (de) * | 2010-02-16 | 2011-08-18 | peptides&elephants GmbH, 14558 | Verfahren zur Erzeugung eines Peptidreinigungsmaterials auf Graphitbasis und Verfahren zur Peptidaufreinigung |
| EP2611904A2 (en) * | 2010-08-31 | 2013-07-10 | Friesland Brands B.V. | Culture medium for eukaryotic cells |
| JP6517692B2 (ja) * | 2012-09-19 | 2019-05-22 | ジェムバックス アンド カエル カンパニー，リミティド | 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物 |
| WO2017178193A1 (en) * | 2016-04-14 | 2017-10-19 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for the identification of random polynucleotide or polypeptide sequences with biological activity |
| CN109575106A (zh) * | 2019-01-07 | 2019-04-05 | 无限极（中国）有限公司 | 一种从大米多肽中制备抗氧化三肽的方法及应用 |
| JP7166039B1 (ja) * | 2020-12-22 | 2022-11-07 | 株式会社マルハチ村松 | ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法 |
| CN116444610B (zh) * | 2022-11-30 | 2024-05-17 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽dasaqfir及其制备方法与应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| EP0243469A4 (en) * | 1985-10-22 | 1988-02-16 | Plant Genetics Inc | Methods and media for enhanced somatic embryogenesis. |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
| EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| JPH1075774A (ja) * | 1996-05-31 | 1998-03-24 | Akzo Nobel Nv | パスツレラ科の弱毒化ｒｔｘ産生細菌 |
| EP0810283A3 (en) | 1996-05-31 | 1997-12-10 | Akzo Nobel N.V. | Live attenuated RTX-procucing bacteria of the family Pasteurellaceae |
| US20020045266A1 (en) * | 2000-02-08 | 2002-04-18 | Hicham Fenniri | Method for determining the structure of an active member of a chemical library |
| US7041506B2 (en) * | 2001-11-19 | 2006-05-09 | Becton Dickinson And Company | Peptides promoting cell adherence, growth and secretion |
| WO2004035608A2 (en) * | 2002-10-18 | 2004-04-29 | Abgenix, Inc. | System and method for cleaving antibodies |
| HRP20131108T1 (hr) * | 2007-09-05 | 2014-01-31 | Genentech, Inc. | Biološki aktivan arginin koji na c-završetku sadrži peptide |
| EP2490021A1 (en) * | 2011-02-18 | 2012-08-22 | Biotempt B.V. | Modulators of PRR and GPCR signalling |
-
2008
- 2008-09-05 HR HRP20131108AT patent/HRP20131108T1/hr unknown
- 2008-09-05 SG SG10201803541TA patent/SG10201803541TA/en unknown
- 2008-09-05 WO PCT/US2008/075403 patent/WO2009033024A1/en not_active Ceased
- 2008-09-05 SG SG2013032669A patent/SG190602A1/en unknown
- 2008-09-05 PL PL08829747T patent/PL2207790T3/pl unknown
- 2008-09-05 EP EP08829747.8A patent/EP2207790B1/en active Active
- 2008-09-05 SI SI200831066T patent/SI2207790T1/sl unknown
- 2008-09-05 JP JP2010524183A patent/JP5734653B2/ja not_active Expired - Fee Related
- 2008-09-05 CN CN200880114757A patent/CN101848925A/zh active Pending
- 2008-09-05 DK DK08829747.8T patent/DK2207790T3/da active
- 2008-09-05 CN CN201510249486.7A patent/CN104844690B/zh not_active Expired - Fee Related
- 2008-09-05 ES ES08829747T patent/ES2434829T3/es active Active
- 2008-09-05 CA CA2697519A patent/CA2697519C/en active Active
- 2008-09-05 US US12/231,917 patent/US20090143248A1/en not_active Abandoned
- 2008-09-05 PT PT88297478T patent/PT2207790E/pt unknown
-
2011
- 2011-02-18 US US12/932,207 patent/US20110183413A1/en not_active Abandoned
-
2013
- 2013-11-05 CY CY20131100975T patent/CY1114618T1/el unknown
-
2015
- 2015-12-24 US US14/757,925 patent/US20170088813A1/en not_active Abandoned
-
2017
- 2017-07-20 US US15/655,279 patent/US20170321187A1/en not_active Abandoned
-
2020
- 2020-09-30 US US17/039,407 patent/US20210163880A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2697519C (en) | 2018-11-20 |
| SG190602A1 (en) | 2013-06-28 |
| SI2207790T1 (sl) | 2013-11-29 |
| EP2207790A1 (en) | 2010-07-21 |
| US20090143248A1 (en) | 2009-06-04 |
| JP2010538089A (ja) | 2010-12-09 |
| HK1213916A1 (zh) | 2016-07-15 |
| CN104844690A (zh) | 2015-08-19 |
| JP5734653B2 (ja) | 2015-06-17 |
| PL2207790T3 (pl) | 2014-01-31 |
| EP2207790B1 (en) | 2013-08-21 |
| SG10201803541TA (en) | 2018-06-28 |
| CN101848925A (zh) | 2010-09-29 |
| ES2434829T3 (es) | 2013-12-17 |
| HRP20131108T1 (hr) | 2014-01-31 |
| US20210163880A1 (en) | 2021-06-03 |
| PT2207790E (pt) | 2013-11-04 |
| CY1114618T1 (el) | 2016-10-05 |
| US20170321187A1 (en) | 2017-11-09 |
| WO2009033024A1 (en) | 2009-03-12 |
| US20110183413A1 (en) | 2011-07-28 |
| CA2697519A1 (en) | 2009-03-12 |
| US20170088813A1 (en) | 2017-03-30 |
| CN104844690B (zh) | 2019-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR22C1054I2 (fr) | Amides peptidiques synthetiques | |
| DK3115370T3 (da) | Biologisk aktive peptider | |
| EP2118122A4 (en) | NOVEL ANTIMICROBIAL PEPTIDES | |
| DK2035447T3 (da) | Polypeptid | |
| BRPI0911743A2 (pt) | "peptídeo" | |
| BRPI0907363A2 (pt) | Métodos e composições relativos a peptídeos e proteínas com elementos de c-terminal | |
| DK2390265T3 (da) | Insulinotropisk peptidderivat med modificeret N-terminal aminosyre | |
| BRPI0814587A2 (pt) | Peptídeos antibióticos | |
| PL2465864T3 (pl) | Szczepionki z peptydem pochodzącym z Eph4 | |
| LT3050576T (lt) | Pegiliuoti rekombinantinio žmogaus augimo hormono junginiai | |
| EP2307038A4 (en) | ELASTIC PEPTIDES COMPREHENSIVE THERAPEUTIC AGENTS | |
| EP2093287A4 (en) | PEPTIDE BINDER IGG | |
| BRPI0812134A2 (pt) | Anatagonistas de cxcr4 de peptídio cíclico | |
| EP2010561A4 (en) | ANTIMICROBIAL PEPTIDES | |
| DK2207790T3 (da) | Biologisk aktive C-terminalt argininholdige peptider | |
| EP2279202A4 (en) | MULTIMER FORMS OF ANTIMICROBIAL PEPTIDES | |
| BRPI1010661A2 (pt) | peptídeo | |
| EP2352730A4 (en) | BIOLOGICAL ACTIVE AMIDE | |
| HRP20150195T1 (xx) | Antibakterijski peptidi | |
| EP2101804A4 (en) | PROANGIOGENIC PEPTIDES | |
| EP2285827A4 (en) | PEPTIDES AND THEIR USES | |
| ATE547425T1 (de) | Optimiertes dengue-virus-eintrittshemmendes peptid (dn81) | |
| DE102008014880A8 (de) | Antientzündliches Polypeptid | |
| DK2021364T3 (da) | Forbedrede antimikrobielle peptider | |
| EP2017285A4 (en) | ANTIMICROBIAL LINEAR PEPTIDES |